Patents by Inventor Russell Jaffe

Russell Jaffe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058376
    Abstract: The present disclosure relates to methods and complexes for ingestion of an elemental magnesium complex as inverted micellar nanodroplets designed to enhance uptake and cell delivery of active constituents. The complex and methods associated with delivery of the elemental magnesium complex disclosed improves many magnesium deficiencies that include cardiovascular, metabolic, neurohormonal, immune defense and repair systems, digestive, behavioral, and community risks.
    Type: Application
    Filed: June 8, 2023
    Publication date: February 22, 2024
    Applicant: RMJH Holdings, LLC
    Inventor: Russell Jaffe
  • Patent number: 11712449
    Abstract: The present disclosure relates to methods and complexes for ingestion of an elemental magnesium complex as inverted micellar nanodroplets designed to enhance uptake and cell delivery of active constituents. The complex and methods associated with delivery of the elemental magnesium complex disclosed improves many magnesium deficiencies that include cardiovascular, metabolic, neurohormonal, immune defense and repair systems, digestive, behavioral, and community risks.
    Type: Grant
    Filed: August 17, 2022
    Date of Patent: August 1, 2023
    Assignee: RMJH Holdings, LLC
    Inventor: Russell Jaffe
  • Publication number: 20160022594
    Abstract: A stable soft gel dosage form for micronized magnesium complexes is provided wherein soft gel capsules containing various magnesium complexes can be stored for prolonged periods under typical home storage conditions with better than 98% or 99% ASA integrity and with negligible physical or chemical deterioration of the soft gelatin capsule over an extended period of time. The stable soft gel capsule is sealed at a selected temperature forming a seam in which the gelatin promotes cross-linking across the heat seam. This method of sealing the soft gel provides for a better seal that cures the weeping problem that can result from the prior methods of heat sealing soft gel capsules.
    Type: Application
    Filed: March 11, 2014
    Publication date: January 28, 2016
    Inventor: Russell JAFFE
  • Publication number: 20130022673
    Abstract: Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts with one or more quaternary amines and/or phosphatides and one or more di- or tri-carboxylic acids, in a one part dosage system or a multi-part dosage system. Increasing magnesium uptake in mammals may also be accomplished by concurrently administering one or more magnesium salts with an organic acid.
    Type: Application
    Filed: September 26, 2012
    Publication date: January 24, 2013
    Inventor: Russell Jaffe
  • Patent number: 8017160
    Abstract: Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts with one or more quaternary amines and/or phosphatides and one or more di- or tri-carboxylic acids.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: September 13, 2011
    Inventor: Russell Jaffe
  • Publication number: 20110183034
    Abstract: Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts with one or more quaternary amines and/or phosphatides and one or more di- or tri-carboxylic acids.
    Type: Application
    Filed: April 8, 2011
    Publication date: July 28, 2011
    Inventor: Russell Jaffe
  • Publication number: 20070243211
    Abstract: The invention relates to compositions comprising a combination of ingredients including one or more oxidative fat metabolizers, neurotransmitters, algin or algin equivalents and medium chain triglycerides that are useful in regulating disorders and maintaining healthy metabolism. The compositions of the invention are useful in enhancing metabolism, burning fat, and enhancing energy.
    Type: Application
    Filed: November 7, 2006
    Publication date: October 18, 2007
    Inventor: Russell Jaffe
  • Publication number: 20070243268
    Abstract: The invention relates to compositions comprising one or more prebiotics (e.g., one or more dietary fibers) in combination with selenium compounds, flavonoids and/or flavonols, and phosphatides. The invention also relates to methods of regulating disorders, specifically disorders of the intestinal tract and related disorders, by administering a composition of the invention.
    Type: Application
    Filed: November 7, 2006
    Publication date: October 18, 2007
    Inventor: Russell Jaffe
  • Publication number: 20050037998
    Abstract: Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts with one or more quaternary amines and/or phosphatides and one or more di- or tri-carboxylic acids.
    Type: Application
    Filed: August 15, 2003
    Publication date: February 17, 2005
    Inventor: Russell Jaffe
  • Patent number: 6632622
    Abstract: An assay method for detecting the response or activation of cells, including lymphocytes, and a method for detecting immunological sensitization in a subject, which involves the introduction of cell-activating substance which causes an enzyme of the cells to become available for reaction, and the measurement of the enzymatic reaction using a substrate which generates a detectable product, and a kit for performing such assays.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: October 14, 2003
    Inventor: Russell Jaffe
  • Patent number: 6620798
    Abstract: Methods for the repair, reconstruction and protection of tissue using compositions containing flavonoids and/or flavonols, including simultaneous administration of agents in order to obtain synergistic effects from the combinations taught and claimed herein. The administration of the flavonols and /or flavonoids in conjuction with compositions containing vitamin C and/or salts and esters of vitamin C provides advantageous sparing of autocoids (internal steroids). The simultaneous administration of flavonols and /or flavonoids to compositions containing glucosamine and or glucosamine sulfate and chondroitin stimulates rapid improvement in joint function. The addition to the flavonoids and/or flavonols to previously administered compositions is a most convenient method of achieving enhanced benefits. The use of combinations of flavonoids and flavonols for use in relieving pain is also a part of the invention.
    Type: Grant
    Filed: June 6, 2000
    Date of Patent: September 16, 2003
    Inventor: Russell Jaffe
  • Patent number: 6545044
    Abstract: Compositions having synergistic effects which make it possible to obtain full beneficial effects of L-glutamine while avoiding the toxic effects that may accompany administration of L-glutamine. This benefit is attained by administration of L-glutamine in conjunction with pyridoxal-alpha-ketoglutarate (PAK). Compositions containing PAK:L-glutamine at a ratio (w/w) of from 1:1 to 1:10 are effective for providing beneficial effects of L-glutamine at nontoxic levels.
    Type: Grant
    Filed: May 30, 2001
    Date of Patent: April 8, 2003
    Inventor: Russell Jaffe
  • Publication number: 20020188010
    Abstract: Compositions having synergistic effects which make it possible to obtain full beneficial effects of L-glutamine while avoiding the toxic effects that may accompany administration of L-glutamine. This benefit is attained by administration of L-glutamine in conjunction with pyridoxal-alpha-ketoglutarate (PAK). Compositions containing PAK:L-glutamine at a ratio (w/w) of from 1:1 to 1:10 are effective for providing beneficial effects of L-glutamine at nontoxic levels.
    Type: Application
    Filed: May 30, 2001
    Publication date: December 12, 2002
    Inventor: Russell Jaffe